DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise
DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 guidance.
Why it matters
Attributed market update with source link for portfolio context.